S,R-Warfarin alcohol

S,R-Warfarin alcohol Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name S,R-Warfarin alcohol
Generic S,R-Warfarin alcohol
Type
Formula C19H18O4
Weight Average: 310.3438
Monoisotopic: 310.120509064
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
S,R-Warfarin alcohol
S,R-Warfarin alcohol

Innovators Monograph

You find simplified version here S,R-Warfarin alcohol

https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=54723704
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99445207
https://www.chemspider.com/Chemical-Structure.25059172.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50408930
https://zinc.docking.org/substances/ZINC000003875291
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL
1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one
2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione
CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE
5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine
1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)
2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE
1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE
(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
CSF oligoclonal banding
Sodium blood test
Sputum fungal smear
Dysphagia Tests
Strep B Test
Leg CT scan
Parainfluenza Tests
Insulin in Blood
Blood sugar test
Cold Stimulation Test
Ureaplasma urethritis
Rheumatic heart disease
Respiratory Syncytial Virus
Non-psychotic generalized anxiety
Spastic Pain of the Abdominal Wall
Hypovolemic
Papillary transitional cell carcinoma of bladder
Severe Fredrickson Type V Hypertriglyceridemia
Postoperative Hemorrhages
Superficial ocular bacterial infections caused by susceptible bacteria